The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The patient experience of prior authorization for cancer care: Anxiety, delays, and the erosion of trust.
 
Fumiko Chino
No Relationships to Disclose
 
Alexandra Baez
Employment - Health First
 
Ivy Beth Elkins
Honoraria - Bayer; Daiichi; Janssen; Merck; Sanofi
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; BMS; Boehringer Ingelheim; Mirati Therapeutics
(OPTIONAL) Uncompensated Relationships - Lilly
 
Emeline Mariam Aviki
No Relationships to Disclose
 
Bridgette Thom
Stock and Other Ownership Interests - AADi (I); AADi (I); Adma Pharma (I); Arcus Biosciences (I); Autolus (I); Autolus (I); Avadel Pharmaceuticals (I); Avidity Biosciences (I); Axonics Modulation Technologies (I); Caladrius Biosciences (I); Chimerix (I); Concert Pharmaceuticals (I); Curis (I); DermTech (I); Halozyme (I); IMV (I); Iovance Biotherapeutics (I); Lipocine (I); Mediwound (I); MEI Pharma (I); Mereo BioPharma (I); Oncternal Therapeutics (I); Pacific Business Group on Health (I); Processa Pharmaceuticals (I); Qiagen (I); Revance Therapeutics (I); Sierra Oncology (I); Sutro Biopharma (I); Zimmer BioMet (I)